NIH-funded research NIH-funded research

Reducing the need for reintubation in high-risk cardiac surgery patients using high-flow nasal cannula.

Official title: Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients with High-Flow Nasal Cannula -the "I-CAN" study

Funded at Vanderbilt University Medical Center · NIH-10819218 · Data updated 2026-11-12

This study is looking at how well high-flow nasal cannula therapy can help prevent the need for reintubation in patients who have just had heart surgery, especially those with other health problems, to improve their recovery and care after the operation.

More Cardiac Surgery research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startMay 15, 2020
Project endApril 30, 2026
Funding year2024
Award (this year)$174,543
NIH project number5K23HL148640-05
Project IDNIH-10819218 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are undergoing high-risk cardiac surgery and may have multiple comorbidities.

Less likely to help

Patients who are not undergoing cardiac surgery or those with minimal health risks may not benefit from this research.

What this research studies

This research investigates the effectiveness of high-flow nasal cannula therapy in preventing reintubation among patients who have undergone cardiac surgery. The study focuses on high-risk individuals, particularly those with multiple health issues, and aims to identify strategies that can reduce the likelihood of needing to reinsert a breathing tube after surgery. By utilizing advanced clinical informatics and pragmatic trial design, the research seeks to gather data that can inform better postoperative care practices. Patients will be monitored closely to assess outcomes related to reintubation rates and overall recovery.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of reintubation, leading to improved recovery outcomes and lower healthcare costs for patients undergoing cardiac surgery.

How similar studies have gone: Previous research has shown promising results in using high-flow nasal cannula therapy in various settings, suggesting potential for success in this novel application for cardiac surgery patients.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Freundlich, Robert Edward — Vanderbilt University Medical Center
  • Study coordinator: Freundlich, Robert Edward

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.